What is IDmission?
IDmission distinguishes itself as one of only two U.S.-based biotech providers and the sole provider of a proprietary, end-to-end solution for identity theft. Its advanced platform offers automatic ID document analysis across various countries and utilizes four categories of biometrics: face, fingerprint, iris, and voice. This robust technological suite positions IDmission as a critical player in identity verification and fraud prevention.
How much funding has IDmission raised?
IDmission has raised a total of $5.2M across 5 funding rounds:
Private Equity
$2M
Private Equity
$1M
Debt
$150K
Debt
$243K
Other Financing Round
$1.8M
Private Equity (2011): $2M, investors not publicly disclosed
Private Equity (2014): $1M, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Debt (2021): $243K featuring PPP
Other Financing Round (2021): $1.8M, investors not publicly disclosed
What's next for IDmission?
The company's recent major enterprise-level funding, characterized as a strategic investment, signals a phase of accelerated growth and market expansion. This capital infusion is expected to bolster IDmission's technological development, enhance its market penetration, and potentially explore new verticals for its identity verification solutions. The focus on scaling its proprietary biometric and AI technology suggests a strategic push to solidify its leadership in the global identity management sector.
See full IDmission company page
